Inventor · disambiguated record
Matthew Forrest Sammons
Also filed as: SAMMONS MATTHEW · SAMMONS MATTHEW F · SAMMONS MATTHEW FORREST
11 granted patents·10 pending applications·13 citations·filing 2014–2025
84Inventor score
Files withPFIZER21
Top patents by PatentIndex Score
21 records- 0193US11452711B2Nitrile-containing antiviral compoundsPFIZER·Filed 2022·Granted Sep 27, 2022·3 cites·8 claims
- 0293US11351149B2Nitrile-containing antiviral compoundsPFIZER·Filed 2021·Granted Jun 7, 2022·6 cites·26 claims
- 0391US11541034B2Nitrile-containing antiviral compoundsPFIZER·Filed 2021·Granted Jan 3, 2023·2 cites·30 claims
- 0484US2025099424A1Nitrile-Containing Antiviral CompoundsPFIZER·Filed 2024·Application pending·0 cites
- 0577US2025084084A1Crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-onePFIZER·Filed 2024·Application pending·0 cites
- 0676US2023120254A1Nitrile-Containing Antiviral CompoundsPFIZER·Filed 2022·Application pending·0 cites
- 0775US9399626B22-thiopyrimidinonesPFIZER·Filed 2014·Granted Jul 26, 2016·2 cites·6 claims
- 0873US12187727B2Methods for antagonizing a melanocortin 4 receptorPFIZER·Filed 2023·Granted Jan 7, 2025·0 cites·20 claims
- 0966US11643412B2Melanocortin 4 receptor antagonists and uses thereofPFIZER·Filed 2021·Granted May 9, 2023·0 cites·20 claims
- 1064US2024238425A1HSD17B13 Inhibitors and/or DegradersPFIZER·Filed 2023·Application pending·0 cites
- 1163US2025051246A1Deuterated Antiviral CompoundsPFIZER·Filed 2024·Application pending·0 cites
- 1260US2024366598A1Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 1359US2025129048A1Melanocortin 4 receptor antagonists and uses thereofPFIZER·Filed 2022·Application pending·0 cites
- 1455US2025304559A1Ether-Linked Antiviral CompoundsPFIZER·Filed 2022·Application pending·0 cites
- 1554US12485157B2Method of treating COVID-19PFIZER·Filed 2021·Granted Dec 2, 2025·0 cites·21 claims
- 1654US12358897B2Compounds and method of treating COVID-19PFIZER·Filed 2021·Granted Jul 15, 2025·0 cites·23 claims
- 1753US9873673B22-thiopyrimidinonesPFIZER·Filed 2016·Granted Jan 23, 2018·0 cites·11 claims
- 1852US11203594B2Anti-proliferative agents for treating PAHPFIZER·Filed 2020·Granted Dec 21, 2021·0 cites·30 claims
- 1950US11926642B2Compounds and methods for the treatment of COVID-19PFIZER·Filed 2021·Granted Mar 12, 2024·0 cites·19 claims
- 2041US2025235510A1Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist peptidesPFIZER·Filed 2025·Application pending·0 cites
- 2141US2025235460A1Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compoundsPFIZER·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Forrest Sammons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →